StockComparison Logo
vs

MREO vs IBO

Comparison between Mereo Biopharma Group Plc (MREO, Company) and NYSE AMEX LISTED TEST STOCK FOR CTS CQS (IBO, Company).

Both MREO and IBO are from the Healthcare sector.

MREO vs IBO - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
MREO
$53M
Winner
IBO
$53M
Max Drawdown
MREO
96.35%
Winner
IBO
92.70%
Sharpe Ratio
MREO
-0.29
Winner
IBO
0.78
5Y Beta
MREO
1.26
Winner
IBO
-0.90
Industry
MREO
Biotechnology
IBO
Biotechnology
P/E Ratio
MREO
-1.27
Winner
IBO
-4.33
Debt to Equity
MREO
0.00%
IBO
0.00%
Free Cash Flow Yield
MREO
-51.14%
Winner
IBO
-3.16%
P/S Ratio
Winner
MREO
109.82
IBO
1437.62
P/B Ratio
Winner
MREO
1.60
IBO
4.83

MREO vs IBO - Historical Returns

Returns include dividend reinvestment.

1M
Winner
MREO
+12.38%
IBO
-12.91%
3M
MREO
-19.90%
Winner
IBO
-12.84%
6M
MREO
-84.80%
Winner
IBO
+22.27%
1Y
MREO
-87.27%
Winner
IBO
+12.45%
5Y(CAGR)
MREO
-38.63%
IBO
N/A
Max(CAGR)
Winner
MREO
-34.70%
IBO
-59.83%

MREO vs IBO - Annual Returns (2019 - 2026)

Returns include dividend reinvestment.

YearMREOIBO
2026-38.64%+8.00%
2025-87.82%-67.21%
2024+52.17%-45.90%
2023+212.16%N/A
2022-55.88%N/A
2021-54.80%N/A
2020+11.53%N/A
2019-49.54%N/A

MREO vs IBO Drawdown Comparison

The maximum drawdown for MREO was -96.35%, occurring on May 6, 2026. This drawdown has not yet recovered.

The maximum drawdown for IBO was -92.70%, occurring on Jun 20, 2025. This drawdown has not yet recovered.

The current MREO drawdown is -95.18%. The current IBO drawdown is -88.71%.

RankMREOIBO
#1-96.35%
Apr 24, 2019 - May 6, 2026
-92.70%
Mar 21, 2025 - Jun 20, 2025
#2N/A-82.57%
Nov 18, 2024 - Mar 21, 2025
#3N/A-53.36%
Sep 16, 2024 - Nov 4, 2024
#4N/A-13.45%
Nov 8, 2024 - Nov 15, 2024
#5N/A-4.45%
Nov 4, 2024 - Nov 7, 2024

Correlation

Correlation between MREO and IBO is 0.75 which considered as a strong positive correlation - the stocks tend to move together.

0.75
-101

Select Stocks to Compare